AbbVie, GMI, WuXi NextCODE Form Alliance to Sequence 45,000 Irish Genomes

AbbVie, a startup called Genomics Medicine Ireland, and WuXi NextCODE have formed a 15-year genomic alliance that proposes to sequence 45,000 Irish genomes. AbbVie will use the data to identify novel targets along with companion diagnostics to discover improved treatments for a number of diseases. The focus will be on oncology, neuroscience and immunology, all areas of interest for AbbVie. Financial details of the agreement were not disclosed. More details.... Stock Symbol: (NYSE: ABBV) Share this with colleagues: // //